DETERMINANTS OF A RISK FOR CHRONIC KIDNEY DISEASE IN DIABETES MELLITUS
- Authors: Vikulova O.1, Zheleznyakova A.1, Nosikov V.2, Shestakova M.1
-
Affiliations:
- Endocrinology Research Center, Moscow
- GosNII Gentika State Genetics Research Center
- Issue: Vol 24, No 10 (2013)
- Pages: 32-34
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115779
- ID: 115779
Cite item
Abstract
The influence of genetic factors on the risk of chronic kidney disease (CKD) was evaluated in patients with type 2 diabetes mellitus. A significant association was found between CKD and polymorphism of the genes (the products of which play a decisive role in the pathogenesis of renal injury) encoding the production of endothelial vasoactive factors (NOS34 gene) and lipid metabolism factors (APOB gene).
Full Text

About the authors
O. Vikulova
Endocrinology Research Center, MoscowCandidate of Medical Sciences
A. Zheleznyakova
Endocrinology Research Center, Moscow
Email: azhelez@gmail.com
V. Nosikov
GosNII Gentika State Genetics Research Center
M. Shestakova
Endocrinology Research Center, Moscow
References
- Викулова O.K. Клинико-лабораторные и генетические факторы развития и прогрессирования диабетической нефропатии у больных сахарным диабетом 1 типа. Автореф. дис.. канд. мед. наук. М., 2003.
- Железнякова А.В., Викулова О.К., Носиков В.В. и др. Генетические факторы развития хронической болезни почек у больных сахарным диабетом 2 типа // Теор. и практ. соврем. науки. - 2012; 2: 364-8.
- Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек. М., 2009.
- Hajhosseiny R., Khavandi K., Goldsmith D. Cardiovascular disease in chronic kidney disease: untying the Gordian knot // Int. J. Clin. Pract. - 2013; 67 (1): 14-31.
- Johns M. (Jr), Paulus-Thomas J. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol // Anal. Biochem. - 1989; 180 (2): 276-8.
- KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney Int. Suppl. - 2013; 3 (1): 1-150.
- Noiri E., Satoh H., Taguchi J. et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease // Hypertension. - 2002; 40 (4): 535-40.
- Shestakova M., Vikulova O., Gorashko N. et al. The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN): Case-control study in type 1 diabetes mellitus (T1DM) // Diabet. Res. Clin. Pract. - 2006; 74 (2): 41-50.
- Wang Y., Kikuchi S., Suzuki H. et al. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases // Nephrol. Dial. Transplant. - 1999; 14 (12): 2898-902.
- Zintzaras E., Papathanasiou A., Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and metaanalysis // Genet. Med. - 2009; 11 (10): 695-706.
Supplementary files
